首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Identification and Characterization of Novel Inhibitors of mPTPB an Essential Virulent Phosphatase from Mycobacterium tuberculosis
【2h】

Identification and Characterization of Novel Inhibitors of mPTPB an Essential Virulent Phosphatase from Mycobacterium tuberculosis

机译:结核分枝杆菌必需的强力磷酸酶mPTPB新型抑制剂的鉴定与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycobacterium protein tyrosine phosphatase B (mPTPB) is an essential virulence factor required for Mycobacterium tuberculosis (Mtb) survival in host macrophages. Consequently, mPTPB represents an exciting new target with a completely novel mechanism of action. We screened a library of 7500 compounds against mPTPB and identified several 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide and piperazinyl-thiophenyl-ethyl-oxalamide derivatives as two distinct classes of mPTPB inhibitors. We showed that both classes of inhibitors are capable of blocking the mPTPB-mediated ERK1/2 inactivation. We further demonstrated that both classes of mPTPB inhibitors are effective in inhibiting the growth of Mtb in macrophages. Thus, improvement of the lead compounds may produce a novel class of anti-TB agents.
机译:分枝杆菌蛋白酪氨酸磷酸酶B(mPTPB)是宿主巨噬细胞中结核分枝杆菌(Mtb)生存所需的必需毒力因子。因此,mPTPB代表了一个激动人心的新目标,它具有全新的作用机制。我们筛选了针对mPTPB的7500种化合物的文库,并确定了几种2-氧-1,2-二氢苯并[cd]吲哚-6-磺酰胺和哌嗪基-硫代苯基-乙基-草酰胺衍生物作为mPTPB抑制剂的两种不同类别。我们表明,这两类抑制剂均能够阻断mPTPB介导的ERK1 / 2失活。我们进一步证明,这两类mPTPB抑制剂均能有效抑制巨噬细胞中Mtb的生长。因此,对先导化合物的改进可以产生一类新型的抗结核药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号